Why is Valiant Organics Ltd falling/rising?

Recent Price Movement and Market Performance

Valiant Organics opened the trading day with a significant gap down of 6.19%, reaching an intraday low of ₹241.05. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure throughout the session. The stock underperformed its sector by 2.76% on the day, and it currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness suggests a bearish sentiment among investors.

Investor participation has also diminished, with delivery volume on 14 Jan falling by 73.49% compared to the five-day average, indicating reduced conviction among shareholders. Although liquidity remains sufficient for modest trade sizes, the lack of robust buying interest is a concern for the stock’s near-term prospects.

Fundamental Strengths Amidst Weak Price Action

Despite the recent price weakness, Valiant Organics has reported encouraging financial results over the last three consecutive quarters. Profit before tax excluding other income surged by 144.36% to ₹7.23 crores, while net profit after tax rose by 144.4% to ₹5.67 crores. The company’s operating profit to interest ratio reached a robust 5.03 times, highlighting improved operational efficiency and reduced financial risk.

Valiant Organics also boasts a return on capital employed (ROCE) of 4.6%, coupled with an enterprise value to capital employed ratio of 1, indicating a very attractive valuation relative to its peers. The stock trades at a discount compared to the average historical valuations of similar companies. Furthermore, the company’s profits have increased by 172.8% over the past year, even as the stock price declined by 22.25%. This disparity is reflected in a low PEG ratio of 0.2, suggesting that the stock may be undervalued based on earnings growth potential.

Long-Term Challenges and Market Sentiment

However, the company’s long-term growth trajectory remains a concern. Operating profit has contracted at an annualised rate of 21.44% over the past five years, signalling structural challenges in sustaining profitability. This poor long-term growth has contributed to the stock’s consistent underperformance against major benchmarks. Over the last one year, the stock has delivered a negative return of 22.25%, while the Sensex gained 8.47%. Over three and five years, the divergence is even starker, with Valiant Organics falling 54.36% and 83.21% respectively, compared to Sensex gains of 39.07% and 70.43%.

Investor confidence appears muted, as evidenced by the absence of domestic mutual fund holdings in the company. Given that mutual funds typically conduct thorough research and hold stakes in companies with strong fundamentals and growth prospects, their lack of participation may indicate reservations about the company’s business model or valuation at current levels.

Conclusion: A Complex Picture for Investors

In summary, Valiant Organics Ltd’s share price decline on 16-Jan reflects a combination of technical weakness, subdued investor participation, and persistent underperformance relative to market benchmarks. While recent quarterly results and valuation metrics offer some positive signals, the company’s poor long-term growth and lack of institutional backing weigh heavily on sentiment. Investors should carefully weigh these factors when considering exposure to this specialty chemicals microcap, recognising that the stock’s current discount may be justified by structural challenges and market scepticism.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →